Neurocrine(IT:1NBIX)
€148.90-2.90 (-1.91%)
IT:1NBIX
Neurocrine earnings date
€148.90
At close:-2.90 (-1.91%)
Neurocrine (1NBIX) Q2 2022 Earnings Report
0 Followers
IT:1NBIX Q2 2022 EPS Results
- Actual EPS
- -EUR 0.16
- Consensus EPS
- EUR 0.55
- Beat/Miss
- Missed by -EUR 0.72
- One Year Ago EPS
- EUR 0.39
IT:1NBIX Q2 2022 Revenue Results
- Actual Revenue
- EUR 343.12M
- Expected Revenue
- EUR 310.58M
- Beat/Miss
- Beat by +EUR 32.55M
- YoY Revenue Growth
- +30.91%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/04/2022
- Time
- After Close
- Conference Call
- Thursday, August 4, 2022
IT:1NBIX Upcoming Earnings
Neurocrine's next earnings date is estimated for February 11, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
IT:1NBIX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 11, 2027 | 2026 (Q4) | 1.88- | 1.34 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | 1.731.78 | 1.85 | -3.92% (-0.07) | |
| Jul 30, 2026 | 2026 (Q2) | 1.501.26 | 0.96 | 31.13% (+0.30) | |
| May 05, 2026 | 2026 (Q1) | 1.101.73 | 0.07 | 2287.50% (+1.66) | |
| Feb 11, 2026 | 2025 (Q4) | 1.641.34 | 0.91 | 48.00% (+0.44) | |
| Oct 28, 2025 | 2025 (Q3) | 1.451.85 | 1.12 | 64.52% (+0.73) | |
| Jul 30, 2025 | 2025 (Q2) | 0.880.96 | 0.57 | 68.25% (+0.39) | |
| May 05, 2025 | 2025 (Q1) | 0.490.07 | 0.38 | -80.95% (-0.31) | |
| Feb 06, 2025 | 2024 (Q4) | 1.460.91 | 1.31 | -30.56% (-0.40) | |
| Oct 30, 2024 | 2024 (Q3) | 1.351.12 | 0.74 | 51.22% (+0.38) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

